Results of 3D conformal radiotherapy in the treatment of localized prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 2, 1997, Pages 311-317

  Fukunaga Johnson, Nina ^a,c   Sandler, Howard M ^a   Mclaughlin, P William ^b   Strawderman, Myla S ^b   Grijalva, Katherine H ^b   Kish, Kathleen E ^a   Lichter, Allen S ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b PROVIDENCE HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

Conformal radiotherapy; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0030762541     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)82499-6     Document Type: Article

References (20)

1. Corn, B. W.; Hanks, G. E.; Schultheiss, T. E.; Hunt, M. A.; Lee, W. R.; Coia, L. R. Conformal treatment of prostate cancer with improved targeting: Superior prostate-specific antigen response compared to standard treatment. Int. J. Radiat. Oncol. Biol. Phys. 32:325-330; 1995.
2. Epstein, B. E.; Peter, R.; Martin, E.; Hanks, G. E. Low complication rate with conformal radiotherapy for cancer of the prostate. Radiother. Oncol. (Suppl.) 24:S100; 1992.
3. Hanks, G. E.; Hanlon, A.; Schultheiss, T.; Corn, B.; Shipley, W. U.; Lee, W. R. Early prostate cancer: The national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation. J. Urol. 152:1775-1780; 1994.
4. Hanks, G. E.; Lee, W. R.; Hanlon, A. L.; Kaplan, E.; Epstein, B.; Schultheiss, T. Conformal technique dose escalation in prostate cancer: Improved cancer control with higher doses in patients with pretreatment PSA > 10 ng/ml. (Abstr.) Proc of 37th Annual ASTRO Meeting. 141; 1995.
5. Kuban, D. A.; El-Mahdi, A. M.; Schellhammer, P. F. Prostate-specific antigen for pretreatment prediction and post-treatment evaluation of outcome after definitive irradiation for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:307-316; 1995.
6. Marsh, L. H.; TenHaken, R. K.; Sandler, H. M. A customized nonaxial external beam technique for treatment of prostate carcinomas. Med. Dosim. 17:123-127; 1992.
7. McShan, D. L.; Fraass, B. A.; Lichter, A. S. Full integration of the beam's eye view concept into computerized treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 18:1485-1494; 1990.
8. Ohori, M.; Wheeler, T. M.; Kattan, M. W.; Goto, Y.; Scardino, P. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J. Urol. 154:1818-1824; 1995.
9. Pickett, B.; Roach, M. 3rd; Verhey, L.; Horine, P.; Malfatti, C.; Akazawa, C.; Dea, D.; Varad, B.; Rathbun, C.; Phillips, T. L. The value of nonuniform margins for six-field conformal irradiation of localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:211-8; 1995.
10. Pilepich, M. V.; Krall, J. M.; al-Sarraf, M.; John, M. J.; Doggert, R. L.; Sause, W. T.; Lawton, C. A.; Abrams, R. A.; Rotman, M.; Rubin, P. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the Radiation Therapy Oncology Group. Urology. 45:616-23; 1995.
11. Pollack, A.; Zagars, G. K.; Starkschall, G.; Childress, C. H.; Kopplin, S.; Boyer, A. L.; Rosen, I. I. Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicity. Int. J. Radiat. Oncol. Biol. Phys. 34:555-564; 1996.
12. Sandler, H. M.; McLaughlin, P. W.; TenHaken, R. K.; Addison, H.; Forman, J.; Lichter, A. Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients. Int. J. Radiat. Oncol. Biol. Phys. 33:797-801; 1995.
13. Sandler, H. M.; McShan, D. L.; Lichter, A. S. Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution. Int. J. Radiat. Oncol. Biol. Phys. 22:361-367; 1992.
14. Sandler, H. M.; Perez-Tamayo, C.; TenHaken, R. K.; Lichter, A. S. Dose escalation for stage C (T3) prostate cancer: Minimal rectal toxicity observed using conformal therapy. Radiat. Oncol. 23:53-54; 1992.
15. Soffen, E. M.; Hanks, G. E.; Hunt, M. A.; Epstein, B. E. Conformal static field radiation therapy treatment of early prostate cancer vs. nonconformal techniques: A reduction in acute morbidity. Int. J. Radiat. Oncol. Biol. Phys. 24:485-488; 1992.
16. TenHaken, R. K.; Perez-Tamayo, D.; Tesser, R. J.; McShan, D. L.; Fraass, B. A.; Lichter, A. S. Boost treatment of the prostate using shaped, fixed fields. Int. J. Radiat. Oncol. Biol. Phys. 16:193-200; 1989.
17. Vijayakumar, S.; Awan, A.; Karrison, T.; Culbert, H.; Chan, S.; Kolker, J.; Low, N.; Halpern, H.; Rubin, S.; Chen, G. T.; Weichselbaum, R. R. Acute toxicity during external-beam radiotherapy for localized prostate cancer: Comparison of different techniques. Int. J. Radiat. Oncol. Biol. Phys. 25:359-371; 1993.
18. Vijayakumar, S.; Chen, G. T. Implementation of three dimensional conformal radiation therapy: Prospects, opportunities, and challenges. Int. J. Radiat. Oncol. Biol. Phys. 33:979-983; 1995.
19. Walsh, P. C.; Partin, A. W.; Epstein, J. I. Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results at 10 years. J. Urol. 152:1831-1836; 1994.
20. Zeitman, A. L.; Coen, J. J.; Dallow, K. C.; Shipley, W. U. The treatment of prostate cancer by conventional radiation therapy: An analysis of long-term outcome. Int. J. Radiat. Oncol. Biol. Phys. 32:287-292; 1995.